E-LIB Suche - Ergebnisse für: Löfling, Lukas

1

Validation of safety outcomes in routinely collected data:L..:

Arena, Patrick J ; Huang, Kui ; Lofling, Lukas...
https://portal.findresearcher.sdu.dk/da/publications/f0e845a8-4602-4ec4-8059-70c333ec6f93. , 2023

Link: https://portal.findresea..

2

Validation of safety outcomes in routinely collected data:L..:

Arena, Patrick J ; Huang, Kui ; Löfling, Lukas...
https://pure.au.dk/portal/da/publications/validation-of-safety-outcomes-in-routinely-collected-data(a6145f1a-f724-41c9-a273-8fcd819dd071).html. , 2023

Link: https://pure.au.dk/porta..

3

Antimuscarinics and lung cancer survival : A Norwegian popu..:

Sanjinez, Claudia ; Botteri, Edoardo ; Stoer, Nathalie C.
Lung Cancer, 0169-5002, 2023, 179,. , 2023

Link: http://urn.kb.se/resolve..

4

Low-dose aspirin and risk of breast cancer: a Norwegian pop..:

Løfling, Lukas ; Støer, Nathalie Charlotte ; Nafisi, Sara...
European Journal of Epidemiology (EJE). , 2023

Link: https://hdl.handle.net/1..

5

Low-dose aspirin and risk of breast cancer: a Norwegian pop..:

Løfling, Lukas ; Støer, Nathalie Charlotte ; Nafisi, Sara...
Løfling, Lukas Støer, Nathalie Charlotte Nafisi, Sara Ursin, Giske Hofvind, Solveig Sand-Hanssen Botteri, Edoardo . Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women. European Journal of Epidemiology (EJE). 2023. , 2023

Link: http://hdl.handle.net/10..

6

Outcomes in patients with lung cancer treated with crizotin..:

Ehrenstein, Vera ; Huang, Kui ; Kahlert, Johnny...
https://pure.au.dk/portal/en/publications/9519b0eb-77ec-4004-820a-241cbe0d61fa. , 2021

Link: https://pure.au.dk/porta..

7

Lung cancer in Sweden : incidence, diagnosis and survival:

Löfling, Lukas
I. Löfling L, Sundström A, Kieler H, Bahmanyar S, Linder M. Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer. Clin Epidemiol. 2019;11:133–143. ::doi::10.2147/CLEP.S186842 ::pmid::30774448 ::isi::000456429300003. , 2020

Link: http://hdl.handle.net/10..

8

Exposure to antimuscarinic medications for treatment of ove..:

Löfling, Lukas ; Sundström, Anders ; Kieler, Helle..
info:eu-repo/semantics/altIdentifier/doi/10.2147/CLEP.S186842. , 2019

Link: https://www.dovepress.co..

9

Clinical characteristics and survival in non-small cell lun..:

Löfling, Lukas ; Karimi, Annette ; Sandin, Fredrik...
Acta Oncologica, 0284-186X, 2019, 58:11, s. 1618-1627. , 2019

Link: http://urn.kb.se/resolve..

10

Pharmacological agents preceding a diagnosis of immune thro..:

Löfling, Lukas ; Linder, Marie ; Ekstrand, Charlotta...
Thrombosis Research, 0049-3848, 2017, 160, s. 27-31. , 2017

Link: http://urn.kb.se/resolve..

11

Maternal and infant characteristics: differences and simila..:

Löfling, Lukas ; Bröms, Gabriella ; Bahmanyar, Shahram.
info:eu-repo/semantics/altIdentifier/doi/10.2147/CLEP.S106126. , 2016

Link: https://www.dovepress.co..

12

Low-dose aspirin, statins, and metformin and survival in pa..:

L. Lukas Löfling ; Nathalie C. Støer ; Bettina Kulle Andreassen..
https://doi.org/10.1186/s13058-023-01697-2. , 2023

Link: https://doi.org/10.1186/..

13

Antimicrobial use in Sweden during the COVID-19 pandemic: p..:

Aya Olivia Nakitanda ; Pär Karlsson ; Lukas Löfling..
https://doi.org/10.1186/s12879-022-07405-3. , 2022

Link: https://doi.org/10.1186/..

14

Patterns of prescription dispensation and over-the-counter ..:

Pär Karlsson ; Aya Olivia Nakitanda ; Lukas Löfling.
https://doi.org/10.1371/journal.pone.0253944. , 2021

Link: https://doi.org/10.1371/..

15

Observed versus predicted volume of dispensed defined daily..:

Pär Karlsson (4386160) ; Aya Olivia Nakitanda (9295988) ; Lukas Löfling (7119512).
https://figshare.com/articles/journal_contribution/Observed_versus_predicted_volume_of_dispensed_defined_daily_doses_of_prescription_medication_per_1000_inhabitants_in_Sweden_for_weeks_in_2020_with_statistically_significant_differences_/15165113. , 2021

Link: https://doi.org/10.1371/..